|
RASSF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.89620000052338E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.58939999734309E-09 |
| Normal-vs-Stage2 |
2.155600E-02 |
| Normal-vs-Stage3 |
1.936330E-03 |
| Normal-vs-Stage4 |
1.730360E-01 |
| Stage1-vs-Stage2 |
1.066200E-01 |
| Stage1-vs-Stage3 |
5.178400E-02 |
| Stage1-vs-Stage4 |
8.433800E-04 |
| Stage2-vs-Stage3 |
8.858600E-01 |
| Stage2-vs-Stage4 |
2.658400E-01 |
| Stage3-vs-Stage4 |
1.409610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.43250000031558E-07 |
| Normal-vs-AfricanAmerican |
5.507400E-01 |
| Normal-vs-Asian |
7.005900E-02 |
| Caucasian-vs-AfricanAmerican |
5.803000E-03 |
| Caucasian-vs-Asian |
1.187760E-01 |
| AfricanAmerican-vs-Asian |
1.783840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00490000001885E-06 |
| Normal-vs-Female |
5.56250000000036E-05 |
| Male-vs-Female |
9.245600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.374400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.783699999513E-07 |
| Normal-vs-Age(61-80Yrs) |
6.2066999999999E-05 |
| Normal-vs-Age(81-100Yrs) |
3.005800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.502200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.245600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.460800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.232600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.333390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.668200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.029200E-04 |
| Normal-vs-Grade 2 |
5.22309999695381E-08 |
| Normal-vs-Grade 3 |
2.169500E-04 |
| Normal-vs-Grade 4 |
7.488300E-02 |
| Grade 1-vs-Grade 2 |
5.183800E-01 |
| Grade 1-vs-Grade 3 |
1.564370E-01 |
| Grade 1-vs-Grade 4 |
8.303900E-02 |
| Grade 2-vs-Grade 3 |
5.069800E-02 |
| Grade 2-vs-Grade 4 |
1.903730E-02 |
| Grade 3-vs-Grade 4 |
3.014400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.15520000232294E-08 |
| Normal-vs-ccB subtype |
3.12920000000716E-06 |
| ccA subtype-vs-ccB subtype |
5.856600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59512999999833E-05 |
| Normal-vs-N1 |
9.687800E-02 |
| N0-vs-N1 |
5.654400E-01 |
|
|
